Analyst Ratings for Acorda Therapeutics Inc. (ACOR)

Updated: 2017-07-27

Shares of Acorda Therapeutics Inc. (NASDAQ:ACOR) have received a consensus rating of Overweight from Wall Street analysts. A consensus rating of Overweight was previously issued for ACOR last month.

8 analysts issued ratings on the stock, where 2 gave ACOR a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has decreased by 1. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Several price targets were given for ACOR by the analysts covering the stock. The highest price target was 35, implying potential capital gains of 61.29 percent. The most pessimistic analyst gave a price target of 17, which equates to a potential downside of -21.66 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Analysts have revised their earnings estimates upwards for this quarter, by about 3.15 percent on average, compared to last month. This can be compared with the average change in earnings estimates over the past 3 months, which is 75.62 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 2.05 percent. If we look at the last 90 days instead, we find a net average change of 26.1 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 1 analysts have revised their quarterly estimates upwards in the past 30 days, while 2 analysts made negative revisions. Also over the last month, 1 analysts increased their estimates for the FY earnings, compared to 2 analysts that revised their FY estimates downwards.

ACOR has traded between a high of 33.00 and a low of 13.60 over the past year. The current market price is above the trailing year's low by 59.56 percent, and 34.24 percent below the high. ACOR has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The ACOR value stock report compares ACOR to some of its peers using value stock charts. The market cap of ACOR is $1.05 billion. ACOR's next earnings release will be on 0000-00-00, which is days away.